Coronavirus COVID-19 Weekly Update 22nd June 2020

Coronavirus COVID-19 Weekly Update 22nd June 2020

This update will be published weekly on Mondays at 12pm GMT and aims to provide clinicians and the public with an overview of the latest data, guidelines, key publications and policy around COVID-19, with links to essential resources and information.

If you are a healthcare professional, please join the discussion on these latest COVID-19 cases on MedShr:

Please post any COVID-19 cases, images or learning points from your clinical practice on MedShr - share key knowledge and experience with a global network of doctors to help improve patient care. Include #COVID19 in your case title.


Please email COVID@medshr.net if you have any data, publications or information you would like to share.

Global Impact of COVID-19 to Date

As of 22nd June 09:00 (GMT)

COVID-19 Cumulative Global Cases

As of 22nd June 09:00 (GMT)

Mapping the coronavirus outbreak

As of 23rd June

Total UK COVID-19 Cases

As of 22nd June

COVID-19 Cumulative UK Cases

As of 22nd June

COVID-19 Daily UK Cases

As of 22nd June

COVID-19 in the African Region

As of 22nd June 09:00 (GMT)

COVID-19 in the Eastern Mediterranean Region

As of 22nd June 09:00 (GMT)

Key Data

Updated 23rd June 2020

Global Covid-19 death toll: Latin America offsets decline in Europe and the US

As of 23rd June

Latest Developments

Latest COVID-19 Publications and Opinion Articles:

New-Onset Diabetes in Covid-19

Published 12th June

This article discusses a bidirectional relationship between Covid-19 and diabetes. On the one hand, diabetes is associated with an increased risk of severe Covid-19. On the other hand, new-onset diabetes and severe metabolic complications of preexisting diabetes, including diabetic ketoacidosis and hyperosmolarity for which exceptionally high doses of insulin are warranted, have been observed in patients with Covid-19.

RECOVERY Trial Preprint: Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report

Published 22nd June 2020

In patients hospitalised with COVID-19, dexamethasone reduced 28-day mortality among those receiving invasive mechanical ventilation or oxygen at randomisation, but not among patients not receiving respiratory support.

Weekly Update by Maryam Borumand, MedShr Open Editorial Team

Comments

Sign in or Register to comment


Matching media queries: